Ultragenyx
Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
Check the tech stack behind ultragenyx.com. Find a founder email at ultragenyx.com.
About
Ultragenyx is a biopharmaceutical company dedicated to developing and delivering transformative treatments for rare and ultrarare genetic diseases where no current options exist. They explore various drug modalities to create the best treatment strategy for each genetic disease they study, serving patients globally. The company is committed to advancing innovative medicines and has a robust pipeline of therapies in development. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Ultragenyx do?
Ultragenyx is a Biotech company that offers Services. Teams look it up for MedTech, HealthTech, Drug Discovery. It is based in Novato, United States and was founded in 2010. Public records show about 1,498 people and $100M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Ultragenyx raised?
Ultragenyx has raised a total of $100M in funding. The most recent round on record is IPO.
Where is Ultragenyx headquartered?
Ultragenyx is headquartered in Novato, United States.
When was Ultragenyx founded?
Ultragenyx was founded in 2010.
What industry does Ultragenyx operate in?
Ultragenyx operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
How many employees does Ultragenyx have?
Ultragenyx has approximately 1,498 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.